Health Care & Life Sciences » Pharmaceuticals | Mezzion Pharma Co. Ltd.

Mezzion Pharma Co. Ltd.

Mezzion Pharma Co. Ltd.
Stock Exchange Korea Exchange
EPS
KRW2623
Market Cap
KRW712.72 B
Shares Outstanding
8.62 M
Public Float
6.07 M

Profile

Address
3th Floor, C&H Building
Seoul SL 06167
Korea, Republic Of
Employees -
Website http://www.mezzion.co.kr
Updated 09/14/2018
Mezzion Pharma Co., Ltd. engages in the development, production, and licensing of pharmaceutical products. Its products include erectile dysfunction, benign prostatic hyperplasia, and fontan therapeutic drugs. The company was founded by Park Dong-Hyun on September 25, 2002 and is headquartered in Seoul, South Korea.

Financials

View All

Dong-Hyun Park
Chief Executive Officer & Director
James L. Yeager
Director, Head-Overseas Research & Development